Skip to content
PMV Pharmaceuticals logo

PMV Pharmaceuticals (PMVP) Q1 2024 Earnings

PMVP·Reported May 9, 2024·Before market open

Diluted EPS came in at $-0.30, beat the $-0.35 consensus by $0.05.

Diluted EPS
$-0.30beat by $0.05
Consensus: $-0.35
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q1 2024

Q1 2024 Earnings FAQ

Common questions about PMV Pharmaceuticals's Q1 2024 earnings report.

PMV Pharmaceuticals (PMVP) reported Q1 2024 earnings on May 9, 2024 before market open.

PMV Pharmaceuticals reported diluted EPS of $-0.30 for Q1 2024.

EPS beat the consensus estimate of $-0.35 by $0.05.

You can read the 10-Q periodic report (0000950170-24-056295) directly on SEC EDGAR. The filing index links above go to sec.gov.